CCR6 and ovarian cancer: In vitro, cisplatin stimulated human macrophage-like THP-1 to become classically activated (CAMs) and to produce CCL20, chemokine ligand 20 (macrophage inflammatory protein-3 (MIP3A), that activates CCR6 on ovarian cancer cells, promoting EMT and migration (230).